Loading clinical trials...
Loading clinical trials...
This is a phase 3, multicenter, randomized, double-blind, placebo controlled study of epirubicin, cisplatin \& capecitabine (ECX) with rilotumumab or placebo for untreated advanced MET-positive gastri...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Amgen
NCT07556640 · Gastric Cancer Stage IV, Peritoneal Metastases From Gastric Cancer, and more
NCT06921928 · Gastric Cancer, Gastroesophageal Junction Cancer, and more
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT07537348 · Advanced Gastric Cancer
NCT06427941 · Metastatic Hepatocellular Carcinoma, Local Advanced Hepatocellular Carcinoma, and more
Research Site
Tucson, Arizona
Research Site
Aurora, Colorado
Research Site
Pueblo, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions